Adage Capital Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Sell |
2,082,383
-1,737,600
| -45% | -$19.6M | 0.04% | 401 |
|
|
2025
Q1 | $38.5M | Sell |
3,819,983
-1,900,000
| -33% | -$19.2M | 0.07% | 284 |
|
|
2024
Q4 | $67.7M | Sell |
5,719,983
-34,752
| -0.6% | -$411K | 0.12% | 169 |
|
|
2024
Q3 | $66.4M | Buy |
5,754,735
+1,819,983
| +46% | +$21M | 0.12% | 187 |
|
|
2024
Q2 | $41.6M | Hold |
3,934,752
| – | – | 0.08% | 249 |
|
|
2024
Q1 | $41.5M | Sell |
3,934,752
-1,340,248
| -25% | -$14.1M | 0.08% | 270 |
|
|
2023
Q4 | $59.2M | Sell |
5,275,000
-925,000
| -15% | -$10.4M | 0.12% | 175 |
|
|
2023
Q3 | $72.4M | Sell |
6,200,000
-4,890,300
| -44% | -$57.1M | 0.16% | 142 |
|
|
2023
Q2 | $112M | Sell |
11,090,300
-3,790,625
| -25% | -$38.2M | 0.24% | 97 |
|
|
2023
Q1 | $110M | Buy |
14,880,925
+5,882,486
| +65% | +$43.4M | 0.25% | 98 |
|
|
2022
Q4 | $71.9M | Buy |
8,998,439
+5,298,439
| +143% | +$42.3M | 0.17% | 145 |
|
|
2022
Q3 | $11.9M | Buy |
3,700,000
+2,700,000
| +270% | +$8.69M | 0.03% | 588 |
|
|
2022
Q2 | $4.07M | Buy |
+1,000,000
| New | +$4.07M | 0.01% | 823 |
|